ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com



Ò½ÏßÒ©ÎÅ1. 5ÔÂ15ÈÕ£¬£¬£¬£¬£¬°¬²®Î¬Ðû²¼£¬£¬£¬£¬£¬ÃÀ¹úFDAÒѼÓËÙÅú×¼ÆìÏ¿¹ÌåżÁªÒ©ÎADC£©Emrelis£¨telisotuzumab vedotin£¬£¬£¬£¬£¬teliso-V£©ÉÏÊУ¬£¬£¬£¬£¬ÓÃÓÚÖÎÁƾßÓиßc-MetÂѰ×Ì«¹ý±í´ï£¨OE£©µÄ¾Ö²¿ÍíÆÚ»ò×ªÒÆÐÔ·ÇÁÛ×´·ÇСϸ°û·Î°©£¨NSCLC£©³ÉÄ껼Õߣ¬£¬£¬£¬£¬ÕâЩ»¼Õß´ËǰÒѽÓÊܹýϵͳÐÔÖÎÁÆ¡£¡£¡£
2. 5ÔÂ15 ÈÕ£¬£¬£¬£¬£¬NMPA ¹ÙÍøÏÔʾ£¬£¬£¬£¬£¬±±º£¿£¿£¿£¿£¿£¿µ³É/Ò©Ã÷ÉúÎïάÀÜÕø ¦Â-CAN103 »ñÅúÉÏÊУ¬£¬£¬£¬£¬ÓÃÓÚ 12 Ëê¼°ÒÔÉÏÇàÉÙÄêºÍ³ÉÈË I ÐÍºÍ ¢ó Ð͸êл²¡»¼Õߵĺã¾ÃÃ¸Ìæ»»ÖÎÁÆ¡£¡£¡£ÕâÒ²ÊÇÖйúÊ׸öÕë¶Ô¸êл²¡¿ª·¢µÄÃ¸Ìæ»»ÁÆ·¨£¨ERT£©¡£¡£¡£
3. 5ÔÂ16ÈÕ£¬£¬£¬£¬£¬CDE¹ÙÍø¹«Ê¾£¬£¬£¬£¬£¬¿ÆÂײ©Ì©É걨µÄ×¢ÉäÓ뿵ɳÍ×Öéµ¥¿¹ÄâÄÉÈëÓÅÏÈÉóÆÀ£¬£¬£¬£¬£¬ÓÃÓÚ¼ÈÍù½ÓÊܹýÄÚÉøÍ¸ÖÎÁÆÇÒÔÚÍíÆÚ»ò×ªÒÆÐԽ׶νÓÊܹýÆäËûϵͳÖÎÁƵIJ»¿ÉÇгýµÄ¾Ö²¿ÍíÆÚ»ò×ªÒÆÐÔ¼¤ËØÊÜÌåÑôÐÔ£¨HR+£©ÇÒÈË±íÆ¤Éú³¤Òò×ÓÊÜÌå2ÒõÐÔ£¨HER2-£©ÈéÏÙ°©³ÉÈË»¼Õß¡£¡£¡£Â«¿µÉ³Í×Öéµ¥¿¹ÊÇÒ»¿îÐÂÐÍTROP2°ÐÏò¿¹ÌåżÁªÒ©ÎADC£©£¬£¬£¬£¬£¬´ËǰÒѾÔÚÖйú»ñÅúÁ½Ïî˳Ӧ֢¡£¡£¡£
4. 5ÔÂ15ÈÕ£¬£¬£¬£¬£¬NMPA¹ÙÍøÐû²¼£¬£¬£¬£¬£¬Åú×¼º£Ë¼¿ÆÉ걨µÄ1ÀàÁ¢ÒìÒ©°²Èð¿Ë·Ò×¢ÉäÒº£¬£¬£¬£¬£¬¸ÃÒ©ÊÊÓÃÓÚÖÎÁƸ¹²¿ÊÖÊõºóµÄÇá¡¢ÖжÈÌÛÍ´¡£¡£¡£¹ûÈ»×ÊÁÏÏÔʾ£¬£¬£¬£¬£¬°²Èð¿Ë·Ò£¨HSK21542£©ÊÇÒ»¿îÍâÖÜkappa°¢Æ¬ÊÜÌåÑ¡ÔñÐÔ¼¤¶¯¼Á¡£¡£¡£
1. ¿ËÈÕ£¬£¬£¬£¬£¬¿Æ°ÔÉúÎïÐû²¼£¬£¬£¬£¬£¬ÒÑÓëÈÕ±¾ÈýÁ⻯ѧ¿Ø¹É¼¯ÍÅÆìϵÄÈýÁâÌï±ßÖÆÒ©ÃÀ¹ú¹«Ë¾£¨Mitsubishi Tanabe Pharma America, Inc., ¼ò³ÆMTPA£©Ç©ÊðÏàÖúÐÒé¡£¡£¡£Ë«·½½«Î§ÈÆÒ»¸öÈ«ÇòÊ×´´µÄÃâÒßϸ°ûÀà°Ðµã£¬£¬£¬£¬£¬¿ª·¢Ò»¿îȫлúÖÆµÄ¿¹ÌåÒ©ÎïżÁªÎADC£©£¬£¬£¬£¬£¬¸ÃÏîÄ¿ÓÐÍû³ÉΪ¶àÖÖʵÌåÁöÊÊÓõġ°Í¨ÓÃÐÍ¡°ADCÖÎÁƼƻ®¡£¡£¡£
1. 5ÔÂ13ÈÕ£¬£¬£¬£¬£¬Ò®Â³´óѧAkiko IwasakiͨѶÔÚ¡¶Nature immunology¡·½ÒÏþÂÛÎÄ¡°Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice¡±£¬£¬£¬£¬£¬·¢Ã÷ÁËÔÚʹÓÃÎÞ×ô¼ÁµÄÖØ×é SARS-CoV-2 ´ÌÍ»ÂѰ׾ÙÐбÇÄÚÔöÇ¿½ÓÖֺ󣬣¬£¬£¬£¬Çý¶¯ð¤Ä¤ IgA ·´Ó¦Éú³¤µÄÒªº¦Ï¸°ûºÍ·Ö×ÓÊÂÎñ¡£¡£¡£
[1]Kwon, Di., Mao, T., Israelow, B. et al. Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice. Nat Immunol (2025). https://doi.org/10.1038/s41590-025-02156-0
Ïà¹ØÐÂÎÅ